Delivery Order SPE2DB20D1109-SPE2DB22FP63P
- Not listed
- This federal contract award, valued at $12,824.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Xeomin 100 unit vials, a specialty pharmaceutical product. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government...
- This federal contract award, valued at $92,332.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $4,103.68 for the supply of 4,558,237,997 units of XEOMIN 200 unit vials. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $6,155.52 in Xeomin 200 unit vials. The award is a firm fixed-price contract with a completion date of January 17, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,193.92 firm fixed-price delivery order is for the supply of 200-unit vials of the pharmaceutical product Xeomin. The contract has a performance period through June 1, 2023 and was awarded on May 10, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $22,018.08 for the supply of XEOMIN 100 unit vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through September 27, 2023. The contract is a Firm Fixed Price type and does not have any set-aside designation, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs)...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,795.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4,564,734,893 vials of the prescription drug XEOMIN 100 UNIT. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award, valued at $5,242.40, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560262540 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at approximately $75.6K to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials. This is a firm fixed-price, non-set-aside contract with a completion date of February 12, 2026, and represents a single delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,508.70 delivery order is for the supply of XEOMIN 100 unit vials, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP63PDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,694.40 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 200-unit vials of the drug Xeomin. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 7/18/22 |